AMD and Retinal Disease News

• Myopia: A Silent and Growing Epidemic The proportion of adults who are nearsighted may be as high as 60% by 2050, according to experts. Yet public awareness about risk factors and preventive measures is low.
  Medscape Medical News, July 14, 2022
• ADA 2022 2-Year Faricimab Results: 'Visual Gains With Fewer Injections' Vision improvements in diabetic macular edema with faricimab were similar to those with aflibercept, with fewer injections, at 2 years. This follows recent FDA approval based on 1-year trial results.
  Medscape Medical News, June 27, 2022
• Alert FDA Approves Brolucizumab for Diabetic Macular Edema Brolucizumab wins approval for diabetic macular edema but with a warning of retinal vasculitis and retinal vascular occlusion.
  FDA Approvals, June 08, 2022
• 10-Year Data Support Supplements for Macular Degeneration Supplements without beta carotene are safe and effective in reducing progression from the moderate to the late stages of age-related macular degeneration.
  Medscape Medical News, June 08, 2022
• Photosensors in Retina Revived After Death Researchers revived light signaling in human donor eyes that were removed from the body up to 5 hours after death, and could restore synaptic transmission within the first hour.
  Reuters Health Information, May 23, 2022
• How Can the US Improve Access to Eyeglasses? Expanding insurance coverage for eye services and standardizing pediatric vision screening requirements across the US are two steps that could help begin to solve the problem, researchers say.
  WebMD Health News, May 23, 2022
• Diabetic Retinopathy Risk, Severity Show Socioeconomic Links Low income and type of health insurance was associated with an increased prevalence of medical risk factors for diabetic retinopathy as well as the risk for vision-threatening disease.
  First Look, May 18, 2022
• ARVO 2022 White People Receive More Macular Degeneration Treatment Non-Hispanic White people get more treatments for wet macular degeneration treatment than people of other races and ethnicities.
  Medscape Medical News, May 06, 2022
• ARVO 2022 Citrus Spray as Antiseptic before Intravitreal Injections? An antimicrobial citrus extract spray could help prevent endophthalmitis before intravitreal injections.
  Medscape Medical News, May 04, 2022
• ARVO 2022 Radiation Retinopathy: Treat-and-Extend Promising A treat-and-extend regimen of intravitreal aflibercept shows promise for stabilizing visual acuity in radiation retinopathy.
  Medscape Medical News, May 02, 2022
• Overweight, Obesity Common in Brazil Teens With Type 1 Diabetes The increased prevalence of overweight and obesity in this population reflects decreased physical activity and increased intake of foods with high calorie density, according to the researchers.
  Medscape Medical News, April 22, 2022
• Is All Type 1 Diabetes the Same? All cases of type 1 diabetes are not the same. New evidence highlights important differences between patients with a hereditary vs sporadic background to the disorder.
  Medscape Medical News, April 22, 2022
• Erectile Dysfunction Drugs Linked With Risk for Eye Problems Popular drugs prescribed for erectile dysfunction may entail an increased risk for adverse eye conditions such as retinal detachment.
  Medscape Medical News, April 20, 2022
• Sexual-Enhancement Drugs Raise Risk of Vision Impairment Men who regularly used Viagra and other popular erectile dysfunction prescription drugs were more likely to suffer visual impairment, including retinal detachment and blindness, a large cohort study finds.
  Reuters Health Information, April 15, 2022
• COVID-19 May Increase Risk for Rare Eye Clots Patients with COVID-19 may have an increased risk of rare vision-threatening blood clots in the eye for months afterward, new findings suggest.
  Reuters Health Information, April 15, 2022
• Erectile Dysfunction Drugs Linked to Ocular Conditions A class of drugs most often prescribed for erectile dysfunction may cause vision-threatening ocular conditions.
  Medscape Medical News, April 13, 2022
• 'Exciting' Findings on Fenofibrate in Diabetic Retinopathy People with diabetic retinopathy who took the cholesterol-lowering drug fenofibrate were less likely to progress to vision-threatening forms of the disease, in a large database study.
  Medscape Medical News, April 07, 2022
• AAN 2022 Gene Therapy Shows Modest Success for Genetic Blindness Gene therapy delivered by intravitreal injection can counter visual degeneration associated with Leber hereditary optic neuropathy, new phase 3 trial data suggest.
  Medscape Medical News, April 04, 2022
• Patient Blinded in One Eye From Surgery Wins $1.2 Million A New York appeals court has upheld a $1.2 million verdict against an eye surgeon after his patient went blind after cataract removal and lens replacement surgery.
  Medscape Medical News, March 29, 2022
• Low Risk of Heart Attack After Eye Procedures, Study Finds Ophthalmologists do not need to routinely delay ophthalmologic procedures in their patients whose blood pressure is not well-controlled, according to study of Scandinavian patient registry data.
  Medscape Medical News, March 22, 2022